TW200833344A - Therapeutic methods and uses of sapogenins and their derivatives - Google Patents
Therapeutic methods and uses of sapogenins and their derivativesInfo
- Publication number
- TW200833344A TW200833344A TW097110333A TW97110333A TW200833344A TW 200833344 A TW200833344 A TW 200833344A TW 097110333 A TW097110333 A TW 097110333A TW 97110333 A TW97110333 A TW 97110333A TW 200833344 A TW200833344 A TW 200833344A
- Authority
- TW
- Taiwan
- Prior art keywords
- derivatives
- therapeutic methods
- sapogenins
- cognitive
- neurodegeneration
- Prior art date
Links
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 230000001149 cognitive effect Effects 0.000 abstract 3
- 230000004770 neurodegeneration Effects 0.000 abstract 2
- 230000002232 neuromuscular Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 230000007850 degeneration Effects 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Landscapes
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses therapeutic methods and uses of certain steroidal sapogenins, related compounds and derivatives thereof, in the treatment of non-cognitive neurodegeneration, non-cognitive neuromuscular degeneration, motor-sensory neurodegeneration or receptor dysfunction or loss in the absence of cognitive, neural and neuromuscular impairment.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP020101170A AR033079A1 (en) | 2001-03-28 | 2002-03-27 | SAPOGENINE DERIVATIVES, SYNTHESIS AND USE, AND METHODS BASED ON USE |
| US36817802P | 2002-03-28 | 2002-03-28 | |
| PCT/GB2002/001578 WO2002079221A2 (en) | 2001-03-28 | 2002-03-28 | Sapogenin derivatives, their synthesis and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200833344A true TW200833344A (en) | 2008-08-16 |
| TWI357816B TWI357816B (en) | 2012-02-11 |
Family
ID=44819106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW097110333A TWI357816B (en) | 2002-03-27 | 2003-03-27 | Therapeutic methods and uses of sapogenins and the |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI357816B (en) |
-
2003
- 2003-03-27 TW TW097110333A patent/TWI357816B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI357816B (en) | 2012-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL164161A0 (en) | Therapeutic methods and uses of sapogenins and their derivatives | |
| WO2002079221A3 (en) | Sapogenin derivatives, their synthesis and use | |
| PT1246835E (en) | Substituted sapogenins and their use | |
| GB9923076D0 (en) | Sapogenin derivatives and their use | |
| PL343508A1 (en) | Smilagenin and anzurogenin-d and their use | |
| TW200528117A (en) | Methods and reagents for the treatment of proliferative diseases | |
| IL146082A0 (en) | Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains | |
| CA2385410A1 (en) | Sapogenin derivatives and their use in the treatment of cognitive dysfunction | |
| WO2001079164A3 (en) | N-substituted dithiocarbamates for the treatment of biological disorders | |
| WO2005000208A3 (en) | Combination therapy for the treatment of neoplasms | |
| GB9923078D0 (en) | Sapogenin derivatives and their use | |
| WO2004007531A3 (en) | Activated checkpoint therapy and methods of use thereof | |
| MXPA02000680A (en) | Vgf polypeptides and methods of treating vgf-related disorders. | |
| WO2004105696A3 (en) | Combination therapy for the treatment of neoplasms | |
| HRP20041009A2 (en) | Theraputic methods and uses of sapogenins and their derivatives | |
| IL171384A (en) | Use of slurp-1 in the preparation of medicaments for the treatment of neurological disorders | |
| TW200833344A (en) | Therapeutic methods and uses of sapogenins and their derivatives | |
| WO2005099754A3 (en) | Maytansinoid analogs as antitumor agents | |
| BR0308788A (en) | Therapeutic processes and uses of sapogenins and their derivatives | |
| AU2003202255A1 (en) | Compositions for treatment of central nervous system neoplasms, and methods of making and using the same | |
| MY134920A (en) | 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia | |
| AU2003251734A1 (en) | Nicergoline, mmdl and mdl for the treatment of neurodegenerative disorders of the retina and optic nerve | |
| WO2004073631A3 (en) | Combination therapy for the treatment of neoplasms | |
| WO2003052066A3 (en) | Klcs as modifiers of the p53 pathway and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |